Organic particles in the micrometer/nanometer size range can find applications in various fields. Unfortunately their production is not a straightforward task for a number of materials. In the present work the production of meloxicam particles in the micrometer range was aimed with the help of pulsed laser ablation in liquid environment (PLAL). Targets pressed from crystalline meloxicam powder were placed in distilled water and irradiated with a focused beam of a frequency doubled (532 nm) nanosecond Nd:YAG laser at 4.2–9.4 J cm −2 fluence. Morphological investigation showed that the produced suspension contained particles in the ~100 nm to 10 µ m size range (1.0–2.0 µ m on average), which is about 10 times smaller than the size of the initial material. FTIR spectroscopic investigations demonstrated that the chemical composition was preserved, while x-ray diffraction and calorimetric measurements indicated partial amorphization of meloxicam during the process. The overall results suggest that the particles are mostly produced by the fragmentation of the pressed target by the recoil forces induced by the laser pulse. Long period sedimentation tests of the suspension combined with UV–vis spectroscopic analysis showed that by the method of PLAL a greater fraction of the poorly water soluble meloxicam could be dispersed and dissolved in water in a pharmaceutically preferred formation than by simple dissolution of it.
1 June 2020 in Journal of Drug Delivery Science and Technology
Recently, the number of water insoluble and poorly soluble drug compounds has increased significantly. Therefore, growing interest has been witnessed in different particle size reduction techniques to improve the dissolution rates, transport characteristics and bioavailability of drugs. Laser ablation has proven to be an alternative method to the production of nano- and micrometre-sized drug particles without considerable chemical damage. We present the nanosecond laser ablation of drug pastilles in distilled water, targeting meloxicam, a poorly water soluble nonsteroidal anti-inflammatory drug, at different laser wavelengths (248 nm, 532 nm and 1064 nm). Besides chemical characterization, crystallinity, morphology and particle size studies, the mechanism of the particle generation process was examined. The applicability of ablated particles in drug formulation was investigated by solubility, cytotoxicity and anti-inflammatory effect measurements. We showed that laser ablation is a clean, efficient and chemically non-damaging method to reduce the size of meloxicam particles to the sub-micrometre–few micrometre size range, which is optimal for pulmonary drug delivery. Complemented by the excellent solubility (four to nine times higher) and anti-inflammatory (four to five times better) properties of the particles compared to the initial drug, laser ablation is predicted to have wider applications in the development of drug formulations.
In pharmaceutical development, more and more drugs are classified as poorly water-soluble or insoluble. Particle size reduction is a common way to fight this trend by improving dissolution rate, transport characteristics and bioavailability. Pulsed laser ablation is a ground-breaking technique of drug particle generation in the nano- and micrometer size range. Meloxicam, a commonly used nonsteroidal anti-inflammatory drug with poor water solubility, was chosen as the model drug. The pastille pressed meloxicam targets were irradiated by a Ti:sapphire laser (τ = 135 fs, λc = 800 nm) in air and in distilled water. Fourier transform infrared and Raman spectroscopies were used for chemical characterization and scanning electron microscopy to determine morphology and size. Additional particle size studies were performed using a scanning mobility particle sizer. Our experiments demonstrated that significant particle size reduction can be achieved with laser ablation both in air and in distilled water without any chemical change of meloxicam. The size of the ablated particles (~50 nm to a few microns) is approximately at least one-tenth of the size (~10–50 micron) of commercially available meloxicam crystals. Furthermore, nanoaggregate formation was described during pulsed laser ablation in air, which was scarcely studied for drug/organic molecules before.